Immunologic Factors: Clinical Trials

9 trials for Immunologic Factors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated, 2 unknown. 5 Phase 1, 5 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 3, Completed 1, Unknown 1
Phase 25Completed 2, Unknown 2, Terminated 1
Not applicable1Completed 1

Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Vaccines, Antiviral Agents
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)92023-04-242025-05-16
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
Ad26.ZEBOV, MVA-BN-Filo - Virus Diseases, Hemorrhagic Fever, Ebola
Phase 2CompletedLondon School of Hygiene and Tropical Medicine1332022-09-192025-05-11
Propranolol on Post Stroke Immune Status and Infection
Propranolol, Ceftriaxone - Stroke, Cerebrovascular Disorders
Phase 2UnknownTianjin Medical University General Hospital452022-06-012022-05-16
Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.
Subunit recombinant vaccine for the prevention of coronavirus infection, Placebo - COVID-19, Immunologic Factors
Phase 1 / Phase 2CompletedSt. Petersburg Research Institute of Vaccines and Sera1552021-07-192023-08-30
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12, Temozolomide - Glioblastoma, Glioma
Phase 1 / Phase 2UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine102020-12-012020-06-09
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
CYNK001-IV, CYNK001-IT - Astrocytoma, Grade IV, Giant Cell Glioblastoma
Phase 1TerminatedCelularity Incorporated32020-10-012022-08-10
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
CYNK-001 - Coronavirus, Coronavirus Infection
Phase 1 / Phase 2TerminatedCelularity Incorporated72020-09-022026-06-26
Natural Killer Cell (CYNK-001) Infusions in Adults with AML
CYNK-001 - Leukemia, Leukemia, Myeloid
Phase 1TerminatedCelularity Incorporated272020-03-122024-12-12
The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response
Meatless, restrictive ketogenic diet - Body Weight, Oxidative Stress
Not applicableCompletedKatarzyna Siedzik142019-10-012026-09-24

Narrower conditions

COVID-19 (2)  ·  Coronavirus Infections (2)  ·  Glioblastoma (2)  ·  Infections (2)  ·  Neoplasms (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Body Weight (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Coronaviridae Infections (1)  ·  Filoviridae Infections (1)

Broader conditions

Astrocytoma (2)  ·  Infections (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Coronaviridae Infections (1)  ·  Glioma (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hyperinsulinism (1)  ·  Lung Diseases (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)

Interventions

Ceftriaxone (1)  ·  Interleukin-12 (1)  ·  Propranolol (1)  ·  Temozolomide (1)

Sponsors

Celularity Incorporated (3)  ·  Katarzyna Siedzik (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  St. Petersburg Research Institute of Vaccines and Sera (1)  ·  Tianjin Medical University General Hospital (1)

Countries

United States (4)  ·  China (2)  ·  Poland (1)  ·  Russia (1)  ·  Sierra Leone (1)

Top investigators

Corey Casper, MD MPH (1)  ·  Deborah Watson-Jones, PhD (1)  ·  Hong Shen, MD (1)  ·  Katarzyna Siedzik, MSc (1)  ·  Richard T Davey, M.D. (1)  ·  Sharmila Koppisetti, M.D (1)  ·  Sharmila Koppisetti, MD (1)